Correlation between thyroid hormone values and anemia in elderly patients with diabetic nephropathy.

Correlación entre los valores de hormonas tiroideas y anemia en pacientes ancianos con nefropatía diabética.

• Jingjing Yu Department of Endocrinology, The Second People’s Hospital of Beilun District, Ningbo Zhejiang Province, Chi https://orcid.org/0009-0003-7126-9306
• Keke Tang Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo Zhejiang Province, C https://orcid.org/0009-0000-9354-2543
• Yan Song Department of Surgery, The Second People’s Hospital of Beilun District, Ningbo, Zhejiang Province, China. https://orcid.org/0009-0006-1900-3203

DOI: https://doi.org/10.54817/IC.v66n2a03

Keywords: correlation, diabetic nephropathy, elderly, anemia severity, thyroid hormone

Abstract

We aimed to explore the correlation between thyroid hormone levels and anemia severity in elderly diabetic nephropathy (DN) patients. Elderly DN patients (140 in total) diagnosed and treated during November 2019 and December 2023 were retrospectively recruited as a DN group, 140 patients with uncomplicated diabetes mellitus as a simple diabetes group, and 140 healthy subjects as a healthy group. A non-anemia group (n=63) and an anemia group (n=77) were set up as sets of the DN group according to the hemoglobin (Hb) level, and the anemia group was further divided into a severe group (n=48) (Hb<60 g/L), a moderate group (n=16) (60 g/L≤Hb<90 g/L)  and  a  mild group (n=13) (Hb≥90 g/L). Compared to the simple diabetes group, signifi- cantly increased levels of serum TSH and significantly decreased levels of FT4 and FT3 were found in the DN group (p<0.05). A significant increase in TSH levels and significant decreases in FT4 and FT3 levels were detected in the serum from the moderate group compared with those from the mild group (p<0.05). The same trends in these levels were observed from the severe group compared to the moderate group (p<0.05). Hb had a negative correlation with TSH and positive correlations with FT4 and FT3 (p<0.05). High TSH and low FT4 and FT3 may be related to anemia in elderly patients with DN, and they have correlations with the severity of anemia.

References

Cao X, Chen P. The effects of alprostadil combined with α-lipoic acid in the treatment of senile diabetic nephropathy. Am J Transl Res. 2021; 13(9): 10823-10829. PMID: 34650761

Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021; 2021(1): 1497449. https://doi.org/10.1155/2021/1497449

Natale P, Palmer SC, Jaure A, Hodson EM, Ruospo M, Cooper TE, Hahn D, Saglimbene VM, Craig JC, Strippoli GF. Hypoxia-inducible factor stabilizers for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2022; 8(8): CD013751. https://doi.org/10.1002/14651858. CD013751.pub2

Gao J, Liu J. Correlation of serum thyrotropin and thyroid hormone levels with diabetic kidney disease: a cross-sectional study. BMC Endocr Disord. 2024; 24(1):170. https://doi.org/10.1186/s12902-024-01699-x

Pavan Kumar JTVK, A UM. Comparison of Thyroid Function Tests Among Type 2 Diabetes Patients With and Without Diabetic Nephropathy and Controls. Cureus. 2024; 16(9): e70462. https://doi.org/10.7759/cureus.70462

Feng X, Huang J, Peng Y, Xu Y. Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease. BMC Endocr Disord. 2021; 21(1): 1. https://doi.org/10.1186/s12902-020-00672-8

Moran GM, Bakhai C, Song SH, Agwu JC; Guideline Committee.. Type 2 diabetes: summary of updated NICE guidance. BMJ. 2022; 377: o775. https://doi.org/10.1136/bmj.o775

Kalra S. The KDIGO guidelines on diabetes and chronic kidney disease, 2020: An appraisal. Diabet Med. 2021; 38(7): e14561. https://doi.org/10.1111/dme.14561

Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021; 18(6): 14791641211058856. https://doi.org/10.1177/14791641211058856

Yang W, Jin C, Wang H, Lai Y, Li J, Shan Z. Subclinical hypothyroidism increases insulin resistance in normoglycemic people. Front Endocrinol. 2023; 14(1):1106968. https://doi.org/10.3389/fendo.2023.1106968

Kim SW, Jeon JH, Moon JS, Jeon EJ, Kim MK, Lee IK, Seo JB, Park KG. Low normal free thyroxine levels in euthyroid male are associated with prediabetes. Diabetes Metab J. 2019; 43(5): 718-726. https://doi. org/10.4093/dmj.2018.0222

Reinhardt W, Mülling N, Behrendt S, Benson S, Dolff S, Führer D, Tan S. Association between albuminuria and thyroid function in patients with chronic kidney disease. Endocrine. 2021; 73(2): 367-373. https://doi.org/10.1007/s12020-021- 02640-1

Liu MC, Li JL, Wang YF, Meng Y, Cai Z, Shen C, Wang MD, Zhao WJ, Niu WQ. Association between thyroid hormones and diabetic kidney disease in Chinese adults. BMC Endocr Disord. 2023; 23(1):56. https://doi.org/10.1186/s12902-023-01299-1

Shi C, Liu X, Du Z, Tian L. Impaired sensitivity to thyroid hormones is associated with the risk of eiabetic nephron pathy in euthyroid patients with Type 1 Diabetes mellitus. Diabetes Metab Syndr Obes. 2024; 17: 611-618. https://doi.org/10.2147/DMSO.S449870

Liu Z. Advance in the correlation between diabetic nephropathy and abnormal serum thyroid hormone levels in patients. Emerg Med Int. 2023; 2023: 8947035. https://doi.org/10.1155/2023/8947035

Han Q, Zhang J, Wang Y, Li H, Zhang R, Guo R, Li L, Teng G, et al. Thyroid hormones and diabetic nephropathy: An essential relationship to recognize. Nephrology. 2019; 24(2): 160-169. https://doi.org/10.1111/nep.13388

Chen Y, Zhang W, Wang N, Wang Y, Wang C, Wan H, Lu Y. Thyroid parameters and kidney disorder in Type 2 diabetes: Results from the METAL Study. J Diabetes Res. 2020; 2020: 4798947. https://doi.org/10.1155/2020/4798947

Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev. 2023; 2(2): CD010590. https://doi.org/10.1002/14651858.CD010590.pub3

Ito K, Yokota S, Watanabe M, Inoue Y, Takahashi K, Himuro N, et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and Aids in clinically predicting a diagnosis of diabetic nephropathy. Intern Med. 2021; 60(9): 1349-1357. https://doi.org/10.2169/internalmedicine.5455-20

Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, Sung S. The prevalence and management of anemia in chronic kidney disease patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci. 2017; 32(2): 249-256. https://doi.org/10.3346/jkms.2017.32.2.249

van Vliet NA, Kamphuis AEP, den Elzen WPJ, Blauw GJ, Gussekloo J, Noordam R, van Heemst D. Thyroid function and risk of anemia: a multivariable-adjusted and mendelian randomization analysis in the UK Biobank. J Clin Endocrinol Metab. 2022; 107(2): e643-e652. https://doi.org/10.1210/clinem/dgab674

Zhao X, Liu F, Yuan S, Wang F, Li C, Guo C, Zhao J. Thyroid hormone replacement therapy in dialysis/renal insufficiency patients. Front Endocrinol. 2025; 16: 1540802. https://doi.org/10.3389/fendo.2025.1540802

Khassawneh AH, Al-Mistarehi AH, Zein Alaabdin AM, Khasawneh L, AlQuran TM, Kheirallah KA, et al. Prevalence and predictors of thyroid dysfunction among type 2 diabetic patients: A case–control study. Int J Gen Med. 2020; 13: 803-816. https://doi.org/10.2147/IJGM.S273900.